WO2015027929A1 - 一种中药组合物 - Google Patents
一种中药组合物 Download PDFInfo
- Publication number
- WO2015027929A1 WO2015027929A1 PCT/CN2014/085362 CN2014085362W WO2015027929A1 WO 2015027929 A1 WO2015027929 A1 WO 2015027929A1 CN 2014085362 W CN2014085362 W CN 2014085362W WO 2015027929 A1 WO2015027929 A1 WO 2015027929A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- salvianolic acid
- component
- chinese medicine
- traditional chinese
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2014314774A AU2014314774B2 (en) | 2013-08-29 | 2014-08-28 | Traditional Chinese medicine composition |
EP14840475.9A EP3040077A4 (en) | 2013-08-29 | 2014-08-28 | Traditional chinese medicine composition |
CA2922231A CA2922231C (en) | 2013-08-29 | 2014-08-28 | Traditional chinese medicine composition |
JP2016537117A JP6372897B2 (ja) | 2013-08-29 | 2014-08-28 | 漢方薬組成物 |
US14/910,088 US10300030B2 (en) | 2013-08-29 | 2014-08-28 | Traditional Chinese medicine composition |
HK16109713.9A HK1221423A1 (zh) | 2013-08-29 | 2016-08-15 | 種中藥組合物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310384234 | 2013-08-29 | ||
CN201310384234.6 | 2013-08-29 | ||
CN201410044675.6 | 2014-01-30 | ||
CN201410044675 | 2014-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015027929A1 true WO2015027929A1 (zh) | 2015-03-05 |
Family
ID=52585606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/085362 WO2015027929A1 (zh) | 2013-08-29 | 2014-08-28 | 一种中药组合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US10300030B2 (zh) |
EP (1) | EP3040077A4 (zh) |
JP (1) | JP6372897B2 (zh) |
CN (1) | CN104415045B (zh) |
AU (1) | AU2014314774B2 (zh) |
CA (1) | CA2922231C (zh) |
HK (1) | HK1221423A1 (zh) |
WO (1) | WO2015027929A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP20186901B (en) | 2013-07-11 | 2018-10-10 | Tasly Pharmaceutical Group Co | Micro-drop-pill-shaped compound and preparation method thereof |
MX2015017697A (es) | 2013-07-11 | 2016-08-03 | Talsy Pharmaceutical Group Co Ltd | Composicion de medicina china tradicional, y preparacion y aplicacion de la misma. |
TWI621443B (zh) | 2013-07-11 | 2018-04-21 | Tasly Pharmaceutical Group Co Ltd | 中藥組合物及其用途、包含該中藥組合物之藥物製劑及複方丹參微滴丸劑、及該微滴丸劑的製備方法 |
CN104418744B (zh) * | 2013-08-29 | 2017-03-01 | 天士力制药集团股份有限公司 | 一种新的丹酚酸化合物t、其制备方法和用途 |
CN107957452A (zh) * | 2016-10-17 | 2018-04-24 | 天士力医药集团股份有限公司 | 一种检测血浆中酚酸类物质的方法 |
CN108310055A (zh) * | 2018-03-23 | 2018-07-24 | 兰纬 | 一种冠心宁注射液的制备方法 |
CN110339202B (zh) * | 2018-04-04 | 2022-10-25 | 天士力医药集团股份有限公司 | 一种药物组合物及其应用 |
CN111876447B (zh) * | 2019-06-25 | 2022-04-01 | 陕西鸿道生物分析科学技术研究院有限公司 | 一种生产迷迭香酸的菌株及方法 |
EP4043012A4 (en) * | 2019-09-30 | 2024-01-24 | Shanghai Inst Materia Medica Cas | MEDICINAL PRODUCTS FOR TREATING ARTERY DISEASES AND USE THEREOF |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759855A (zh) * | 2004-10-15 | 2006-04-19 | 合肥恒星药物研究所 | 一种治疗慢性肝炎的药物 |
CN102526186A (zh) * | 2012-01-17 | 2012-07-04 | 中国中医科学院广安门医院 | 一种用于预防和治疗心血管疾病的药物组合物及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1414011A (zh) | 2002-10-17 | 2003-04-30 | 南开大学 | 三七皂苷的提取方法 |
CN100443086C (zh) | 2004-02-06 | 2008-12-17 | 徐琲琲 | 人参皂苷-Re的制备方法 |
CN100450501C (zh) * | 2004-03-17 | 2009-01-14 | 天津天士力制药股份有限公司 | 一种治疗心脑血管疾病的中药制剂及其制备方法 |
CN1951892B (zh) | 2005-10-21 | 2010-10-27 | 山东绿叶天然药物研究开发有限公司 | 一种原儿茶醛的制备方法 |
CN100335897C (zh) | 2005-11-02 | 2007-09-05 | 中国药科大学 | 一种含有丹参和三七药材的复方制剂的质量检测方法 |
CN100512830C (zh) * | 2006-05-17 | 2009-07-15 | 广州白云山和记黄埔中药有限公司 | 治疗老年痴呆症的药物组合物 |
CN101508965B (zh) | 2008-10-27 | 2011-08-03 | 昆明诺唯金参生物工程有限责任公司 | 一种链霉菌发酵三七皂苷制备20(S)-人参皂苷Rh1的方法 |
US20120041062A1 (en) | 2009-03-30 | 2012-02-16 | Tianjin Tasly Pharmaceutical Co., Ltd. | Compound of salvianolic acid l, preparation method and use thereof |
CN102675407B (zh) | 2011-03-11 | 2015-11-25 | 上海医药工业研究院 | 一种隐丹参酮的制备方法 |
CN102908355B (zh) | 2011-08-04 | 2014-06-04 | 中国科学院上海药物研究所 | 一种药物组合物及其用途 |
CN102757336B (zh) | 2012-07-17 | 2014-11-05 | 湖北远成赛创科技有限公司 | 咖啡酸的制备方法 |
-
2014
- 2014-08-28 EP EP14840475.9A patent/EP3040077A4/en active Pending
- 2014-08-28 US US14/910,088 patent/US10300030B2/en active Active
- 2014-08-28 CA CA2922231A patent/CA2922231C/en active Active
- 2014-08-28 WO PCT/CN2014/085362 patent/WO2015027929A1/zh active Application Filing
- 2014-08-28 AU AU2014314774A patent/AU2014314774B2/en active Active
- 2014-08-28 JP JP2016537117A patent/JP6372897B2/ja active Active
- 2014-08-29 CN CN201410436126.3A patent/CN104415045B/zh active Active
-
2016
- 2016-08-15 HK HK16109713.9A patent/HK1221423A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759855A (zh) * | 2004-10-15 | 2006-04-19 | 合肥恒星药物研究所 | 一种治疗慢性肝炎的药物 |
CN102526186A (zh) * | 2012-01-17 | 2012-07-04 | 中国中医科学院广安门医院 | 一种用于预防和治疗心血管疾病的药物组合物及其用途 |
Non-Patent Citations (7)
Title |
---|
"New Pharmaceutics", pages: 264 |
BULLETIN OF MEDICAL RESEARCH, vol. 30, no. 7, 2001 |
CHINA JOURNAL OF MORDEN MEDICINE, vol. 7, no. 4, 1997, pages 42 |
JOURNAL OF XINJIANG MEDICAL UNIVERSITY, vol. 25, no. 3, 2002 |
NANFANG JOURNAL OF NURSING, vol. 3, no. 5, 1996, pages 7 - 9 |
See also references of EP3040077A4 |
SHANXI MEDICINE JOURNAL, vol. 25, no. 2, 1996, pages 315 |
Also Published As
Publication number | Publication date |
---|---|
HK1221423A1 (zh) | 2017-06-02 |
AU2014314774A1 (en) | 2016-02-25 |
US10300030B2 (en) | 2019-05-28 |
EP3040077A4 (en) | 2017-06-07 |
CN104415045B (zh) | 2019-03-22 |
EP3040077A1 (en) | 2016-07-06 |
AU2014314774B2 (en) | 2019-04-18 |
JP6372897B2 (ja) | 2018-08-15 |
JP2016531911A (ja) | 2016-10-13 |
CN104415045A (zh) | 2015-03-18 |
US20160184249A1 (en) | 2016-06-30 |
CA2922231C (en) | 2021-08-24 |
CA2922231A1 (en) | 2015-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2922231C (en) | Traditional chinese medicine composition | |
EP2415749B1 (en) | New salvianolic acid compound l, preparation method and use thereof | |
AU2014289766B2 (en) | Traditional chinese medicine composition, and preparation and application thereof | |
AU2014314827B2 (en) | New salvianolic acid compound T, preparation method therefor, and use thereof | |
EP3020408B1 (en) | Traditional chinese medicine composition, and preparation and application thereof | |
US20070254847A1 (en) | Pharmaceutical Composition Containing Steroidal Saponins, the Preparation Method and Use Thereof | |
US20080187608A1 (en) | Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases | |
CN101721467B (zh) | 丹参总酚酸制备方法 | |
CN106467509A (zh) | 丹酚新酸化合物及其制备方法和应用 | |
JPH1087691A (ja) | 三七人参由来の新規サポニン配糖体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14840475 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14910088 Country of ref document: US |
|
REEP | Request for entry into the european phase |
Ref document number: 2014840475 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014840475 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2922231 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2014314774 Country of ref document: AU Date of ref document: 20140828 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2016537117 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |